University Medical Center Hamburg-Eppendorf-ko ikertzaileekin lankidetzan egindako argitalpenak (74)

2024

  1. ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies

    Blood, Vol. 144, Núm. 11, pp. 1193-1205

  2. Gender sensitivity of the COVID-19 mental health research in Europe: a scoping review

    International Journal for Equity in Health, Vol. 23, Núm. 1

  3. Metabolic Acidosis Is Associated With an Accelerated Decline of Allograft Function in Pediatric Kidney Transplantation

    Kidney International Reports, Vol. 9, Núm. 6, pp. 1684-1693

  4. One-year employment outcome prediction after traumatic brain injury: A CENTER-TBI study

    Disability and Health Journal

  5. Recent outcomes of liver transplantation for Budd-Chiari syndrome: A study of the European Liver Transplant Registry (ELTR) and affiliated centers

    Hepatology, Vol. 80, Núm. 1, pp. 136-151

  6. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

    Brain, Vol. 147, Núm. 8, pp. 2652-2667

  7. Severe steroid-related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy—An observational Ponte di Legno Toxicity Working Group Study

    British Journal of Haematology, Vol. 205, Núm. 4, pp. 1450-1459

  8. The “Woundosome” Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia

    Journal of Endovascular Therapy

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Gender differences in the management of acute psychiatric episodes in the emergency department: a cross-sectional analysis of the 2017–2019 triennium

    Archives of Women's Mental Health, Vol. 26, Núm. 6, pp. 777-783

  3. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma

    Journal of Hepatology, Vol. 79, Núm. 1, pp. 93-108

  4. Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification

    Acta Neuropathologica, Vol. 145, Núm. 5, pp. 651-666

  5. Prognostic Models for Global Functional Outcome and Post-Concussion Symptoms Following Mild Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study

    Journal of Neurotrauma, Vol. 40, Núm. 15-16, pp. 1651-1670

  6. Treatment and long-term outcome in primary nephrogenic diabetes insipidus

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 10, pp. 2120-2130

2022

  1. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  2. Health care utilization and outcomes in older adults after Traumatic Brain Injury: A CENTER-TBI study

    Injury, Vol. 53, Núm. 8, pp. 2774-2782

  3. Hypersensitivity to Pegylated E.colia sparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group

    European Journal of Cancer, Vol. 162, pp. 65-75

  4. Measurement invariance of six language versions of the post-traumatic stress disorder checklist for DSM-5 in civilians after traumatic brain injury

    Scientific Reports, Vol. 12, Núm. 1

  5. Neurocognitive correlates of probable posttraumatic stress disorder following traumatic brain injury

    Brain and Spine, Vol. 2

  6. PIGN encephalopathy: Characterizing the epileptology

    Epilepsia, Vol. 63, Núm. 4, pp. 974-991